Published in Brain Res Bull on March 24, 2006
Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats. Exp Neurol (2009) 1.02
IGF-1 can either protect against or increase LPS-induced damage in the developing rat brain. Pediatr Res (2010) 0.87
Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy. Cerebellum (2011) 0.85
Intranasal administration of insulin-like growth factor-1 protects against lipopolysaccharide-induced injury in the developing rat brain. Neuroscience (2011) 0.82
Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art. Expert Opin Drug Deliv (2013) 0.79
Therapy development for spinal muscular atrophy in SMN independent targets. Neural Plast (2012) 0.78
Activation of p38MAPK contributes to expanded polyglutamine-induced cytotoxicity. PLoS One (2008) 0.77
IGF-1 in Friedreich's Ataxia - proof-of-concept trial. Cerebellum Ataxias (2014) 0.77
Neuroprotective role of liver growth factor "LGF" in an experimental model of cerebellar ataxia. Int J Mol Sci (2014) 0.77
Effects of intravenous administration of human umbilical cord blood stem cells in 3-acetylpyridine-lesioned rats. Stem Cells Int (2012) 0.76
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial. Cerebellum Ataxias (2014) 0.75
Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system. Drug Des Devel Ther (2016) 0.75
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis (2009) 8.37
Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry (1999) 5.63
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis (2010) 5.24
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell (2001) 4.25
Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet (1997) 4.12
Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron (1997) 3.73
The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med (2001) 3.39
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A (2013) 2.31
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A (2000) 2.26
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology (2008) 2.17
Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology (2006) 2.17
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis (2010) 1.87
Diffusion and convection in normal and neoplastic tissues. Cancer Res (1974) 1.71
Human Angiostrongylus cantonensis: an update. Eur J Clin Microbiol Infect Dis (2011) 1.51
Gametic and somatic tissue-specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1. Nat Genet (1995) 1.51
Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis. Acta Haematol (2013) 1.47
Frequent p53 mutations in head and neck cancer. Cancer Res (1992) 1.46
Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene (1991) 1.45
A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat Genet (1996) 1.45
Inhibition of immunoglobulin folding and secretion by dominant negative BiP ATPase mutants. Proc Natl Acad Sci U S A (1996) 1.41
Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset. Am J Hum Genet (1994) 1.38
Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res (1993) 1.36
New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology (2012) 1.35
The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry (1998) 1.34
Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res (1994) 1.32
DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene (1996) 1.31
Subcellular localization of the Iitracellular survival-enhancing Eis protein of Mycobacterium tuberculosis. Infect Immun (2001) 1.29
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord (2010) 1.29
Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system. J Gene Med (2000) 1.27
Perfusion deficit parallels exacerbation of cerebral ischemia/reperfusion injury in hyperglycemic rats. J Cereb Blood Flow Metab (1997) 1.22
Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype. Neurology (2002) 1.20
T4 Bacteriophage-coded RNA polymerase subunit blocks host transcription and unfolds the host chromosome. Nature (1977) 1.20
hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer (2010) 1.19
Association of age-related mitochondrial abnormalities with skeletal muscle fiber atrophy. Free Radic Biol Med (1998) 1.18
Genetic study of indirect inguinal hernia. J Med Genet (1994) 1.16
A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology (2000) 1.16
Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J Antimicrob Chemother (1998) 1.15
Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis (2013) 1.15
Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease. Ann Neurol (1995) 1.15
Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J Neurosci Res (1996) 1.14
Interactions between coilin and PIASy partially link Cajal bodies to PML bodies. J Cell Sci (2005) 1.13
Chinese herbal medicine suxiao jiuxin wan for angina pectoris. Cochrane Database Syst Rev (2008) 1.13
Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma. Oncogene (2012) 1.11
Fertile mule in China and her unusual foal. J R Soc Med (1985) 1.11
Familial patent ductus arteriosus. Am J Cardiol (1984) 1.10
Isolation and identification of hepatitis E virus in Xinjiang, China. J Gen Virol (1992) 1.09
[Isolation and identification of Leclercia adecarboxylate in clinical isolates in China]. Wei Sheng Wu Xue Bao (1992) 1.09
p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett (1993) 1.09
Tick paralysis. Semin Neurol (2004) 1.08
Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol (1998) 1.07
"Orthostatic tremor' in familial-essential tremor. Neurology (1986) 1.07
Purified and sterilized magnetosomes from Magnetospirillum gryphiswaldense MSR-1 were not toxic to mouse fibroblasts in vitro. Lett Appl Microbiol (2007) 1.07
Re: Osteoporosis after orchiectomy for prostate cancer. J Urol (1998) 1.06
Development of a degradable cement of calcium phosphate and calcium sulfate composite for bone reconstruction. Biomed Mater (2006) 1.06
Influence of culture media and environmental factors on mycelial growth and conidial production of Diplocarpon mali. Lett Appl Microbiol (2010) 1.05
Protein kinase A phosphorylation alters Kvbeta1.3 subunit-mediated inactivation of the Kv1.5 potassium channel. J Biol Chem (1999) 1.04
Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int J Cancer (1996) 1.04
CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann Neurol (2005) 1.04
Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations. Oncogene (2008) 1.03
[Analysis of the eye's anterior segment with optical coherence tomography. Static and dynamic study]. J Fr Ophtalmol (2005) 1.02
Primary role of the barely occupied states in the charge density wave formation of NbSe2. Phys Rev Lett (2008) 1.02
BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy. J Urol (1999) 1.01
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies. Ann Oncol (2014) 1.01
Analysis of factors influencing the rate of germination of spores of Bacillus subtilis by very high pressure. J Appl Microbiol (2007) 1.01
Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP. Biochemistry (2001) 1.01
Measurements of serotonin and related indoles using capillary electrophoresis with multiphoton-induced hyperluminescence. Anal Biochem (1998) 0.99
Rational selection of small molecules that increase transcription through the GAA repeats found in Friedreich's ataxia. FEBS Lett (2006) 0.99
Electronic structure and unusual exchange splitting in the spin-density-wave state of the BaFe2As2 parent compound of iron-based superconductors. Phys Rev Lett (2009) 0.99
A novel cellular stress response characterised by a rapid reorganisation of membranes of the endoplasmic reticulum. Cell Death Differ (2012) 0.98
A monoclonal antibody shows discrete cellular and subcellular localizations of mGluR1 alpha metabotropic glutamate receptors. J Chem Neuroanat (1997) 0.98
Reduced immunoreactivity to calcium-binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice. Neurology (1998) 0.97
Calcium homeostasis and spinocerebellar ataxia-1 (SCA-1). Brain Res Bull (2001) 0.97
Development of heritable melanoma in transgenic mice. J Invest Dermatol (1998) 0.96
Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum. Int J Cancer (1996) 0.96
Perfusion scan in pulmonary tumor microembolism: report of a case. J Formos Med Assoc (1991) 0.96
Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro. J Mol Neurosci (2012) 0.96
Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts. Br J Pharmacol (2008) 0.95
Chromatic induction: border contrast or adaptation to surrounding light? Vision Res (1998) 0.95
The CLDN5 locus may be involved in the vulnerability to schizophrenia. Eur Psychiatry (2004) 0.94
Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer. Int J Cancer (1998) 0.94
Treatment of trochanteric fractures with proximal femoral nail antirotation or dynamic hip screw systems: a meta-analysis. J Int Med Res (2012) 0.93
Puerarin injection for unstable angina pectoris. Cochrane Database Syst Rev (2006) 0.93
Long-term safety of dichloroacetate in congenital lactic acidosis. Mol Genet Metab (2013) 0.93
Monitoring enzyme catalysis with mass spectrometry. J Biol Chem (2000) 0.93
Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats. J Biomed Sci (1999) 0.92
Viral capsid mobility: a dynamic conduit for inactivation. Proc Natl Acad Sci U S A (2001) 0.92
Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality. Cancer (2001) 0.92
Free-standing ZnO-CuO composite nanowire array films and their gas sensing properties. Nanotechnology (2011) 0.92
Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies. Clin Pharmacol Ther (2015) 0.92
The protective effect of niacinamide on ischemia-reperfusion-induced liver injury. J Biomed Sci (2001) 0.91
Testosterone augments neuronal Fos responses to estrous odors throughout the vomeronasal projection pathway of gonadectomized male and female rats. Horm Behav (1998) 0.91
The weaver mutation changes the ion selectivity of the affected inwardly rectifying potassium channel GIRK2. FEBS Lett (1996) 0.91
Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol (1995) 0.90
Suppression of heat-induced hsp70 expression by the 70-kDa subunit of the human Ku autoantigen. Proc Natl Acad Sci U S A (1995) 0.90
Ferritin gene organization: differences between plants and animals suggest possible kingdom-specific selective constraints. J Mol Evol (1996) 0.90
Mutation in the kv3.3 voltage-gated potassium channel causing spinocerebellar ataxia 13 disrupts sound-localization mechanisms. PLoS One (2013) 0.90
Relationship between ataxin-1 nuclear inclusions and Purkinje cell specific proteins in SCA-1 transgenic mice. J Neurol Sci (2000) 0.90
What is Kearns-Sayre syndrome after all? Arch Neurol (2001) 0.90
Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors. Urology (2000) 0.90